Cardiff Oncology (CRDF) Other financing activities (2013 - 2025)

Cardiff Oncology has reported Other financing activities for 10 years, with the latest figure at $2.1 million in Q4 2025.

• Quarterly Other financing activities rose 15746.15% year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (up 459.79% YoY) and the FY2025 annual result came in at $2.1 million, up 459.79% from the prior year.
• Other financing activities climbed to $2.1 million in Q4 2025 per CRDF's latest filing, from $25000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $2.1 million in Q4 2025 and troughed at -$1.3 million in Q3 2021.
• A 4-year average of $281777.8 and a median of $75000.0 in 2022 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2021 and 2025: Other financing activities sank 8520.0% in 2021, then surged 15746.15% in 2025.
• Over 4 years, Other financing activities stood at -$1.3 million in 2021, then soared by 105.94% to $75000.0 in 2022, then plunged by 82.67% to $13000.0 in 2024, then soared by 15746.15% to $2.1 million in 2025.
• According to Business Quant data, Other financing activities over the past three periods registered $2.1 million, $25000.0, and $3000.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.